Copyright
©The Author(s) 2022.
World J Gastroenterol. Mar 7, 2022; 28(9): 918-932
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.918
Published online Mar 7, 2022. doi: 10.3748/wjg.v28.i9.918
Figure 2 Cystic fibrosis transmembrane conductance regulator can protect the Caco2 cells from apoptosis induced by the hypoxia/reoxygenation.
A: Representative Western blotting and quantification data for cystic fibrosis transmembrane conductance regulator (CFTR) after the hypoxia/reoxygenation (H/R) treatment, bP < 0.001 vs control (n = 3); B: Representative Western blotting and quantification data for CFTR after the LV-CFTR transfection, bP < 0.001 vs control (n = 3); C: Cell viability was tested using the CCK8 kit after the LV-CFTR transfection, bP < 0.001 vs control (n = 3); D: Representative Western blotting and quantification data for cell apoptotic proteins Bcl-2 and Bax after the LV-CFTR transfection. Data are presented as mean ± SD. bP < 0.001 vs control (n = 3). CFTR: Cystic fibrosis transmembrane conductance regulator; H/R: Hypoxia/reoxygenation.
- Citation: Dong ZW, Liu H, Su FF, Fan XZ, Zhang Y, Liu P. Cystic fibrosis transmembrane conductance regulator prevents ischemia/reperfusion induced intestinal apoptosis via inhibiting PI3K/AKT/NF-κB pathway. World J Gastroenterol 2022; 28(9): 918-932
- URL: https://www.wjgnet.com/1007-9327/full/v28/i9/918.htm
- DOI: https://dx.doi.org/10.3748/wjg.v28.i9.918